BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 158 filers reported holding BLUEBIRD BIO INC in Q1 2024. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,020,988 | -23.1% | 1,037,379 | 0.0% | 0.30% | -8.2% |
| Q1 2024 | $1,327,845 | -61.5% | 1,037,379 | -58.5% | 0.33% | -56.8% |
| Q4 2023 | $3,450,000 | +26.1% | 2,500,000 | +177.8% | 0.77% | +13.8% |
| Q3 2023 | $2,736,000 | +152.9% | 900,000 | +3500.0% | 0.67% | +219.4% |
| Q4 2020 | $1,082,000 | -19.8% | 25,000 | 0.0% | 0.21% | -12.4% |
| Q3 2020 | $1,349,000 | -11.6% | 25,000 | 0.0% | 0.24% | -10.7% |
| Q2 2020 | $1,526,000 | – | 25,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |